Contineum Therapeutics (CTNM) Enterprise Value (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Enterprise Value of -$236.6 million for Q2 2026, down 34.8% year-over-year from -$362.8 million in Q2 2025, and up 3.97% quarter-over-quarter from -$246.3 million in Q1 2026.
Contineum Therapeutics (CTNM) Enterprise Value (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Enterprise Value history runs 4 years deep, the most recent figure standing at -$236.6 million for Q2 2026.
- In Q2 2026, Enterprise Value fell 34.8% year-over-year to -$236.6 million; the TTM figure through Jun 2026 stood at -$236.6 million (down 34.8% YoY), while the FY2025 annual figure was -$262.9 million, down 28.39% from the prior year.
- Enterprise Value for Q2 2026 stood at -$236.6 million, up from -$246.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$117.9 million in Q1 2024, with the low at -$262.9 million in Q4 2025.
- The 4-year median for Enterprise Value is -$204.8 million (2024), against an average of -$197.7 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value sank 63.56% in 2024, then grew 19.74% in 2025.
- Contineum Therapeutics' Enterprise Value stood at -$125.2 million in 2023, then tumbled by 63.56% to -$204.8 million in 2024, then decreased by 28.39% to -$262.9 million in 2025, then climbed by 10.02% to -$236.6 million in 2026.
- Business Quant data shows CTNM's Enterprise Value at -$236.6 million in Q2 2026, -$246.3 million in Q1 2026, and -$262.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | -236.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -236.55 Mn |
| Mar 31, 2026 | -246.33 Mn |
| Dec 31, 2025 | -262.90 Mn |
| Sep 30, 2025 | -182.41 Mn |
| Jun 30, 2025 | -175.48 Mn |
| Mar 31, 2025 | -190.71 Mn |
| Dec 31, 2024 | -204.76 Mn |
| Sep 30, 2024 | -213.91 Mn |
| Jun 30, 2024 | -218.65 Mn |
| Mar 31, 2024 | -117.91 Mn |
| Dec 31, 2023 | -125.19 Mn |